Active Ingredient History

Dicobalt edetate was developed as a cyanide antidote based on the known ability of cobalt to form stable complexes with cyanide. One current cobalt-based antidote available in Europe is dicobalt-EDTA, sold as Kelocyanor. This agent chelates cyanide as the cobalticyanide. This drug provides an antidote effect more quickly than formation of methemoglobin. It can be very toxic and cause seizures, upper airway oedema, chest pain, hypotension, vomiting, rashes and dyspnoea especially in those who have not be exposed to cyanide.   NCATS

  • SMILES: [Co++].[Co++].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O
  • Mol. Mass: 406.0773
  • ALogP: Missing data
  • ChEMBL Molecule:
More Chemistry
cobalt-edta complex | cobalt-ethylenediamine tetraacetic acid chelate | cobalt-ethylenediamine tetraacetic acid chelate, disodium salt | cobalt tetracemate | dicobalt edetate | edta-cobalt chelate | kelocyanor


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue